13F filer · CIK 1103804 ↗
Viking Global
You are looking at Q1 2024. See the latest, Q2 2026 →
Reported value
$26.86B
−1.6% on the quarter before
Positions
83
22 new · 18 sold out
Top 10
40.9%
of the value
Est. gain
+$1.01B
on stocks held all quarter
Est. return
+5.6%
on those stocks since Q4 2023
Positions as of Mar 31, 2024, from Viking Global's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
Each tile is a position, sized by its share, colored by what the fund did with it since Q4 2023. Striped tiles are options.
Largest buys
Since Q4 2023, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Las Vegas Sands Corp~$874.9MNew · 0.0% → 3.3%+16,923,581 shares
- Microsoft~$671.8MNew · 0.0% → 2.5%+1,596,887 shares
- Apple~$663.8MNew · 0.0% → 2.5%+3,870,990 shares
- Us Bancorp Del~$583.6MAdded · 1.5% → 3.8%+13,056,827 shares
- T-Mobile Us Inc~$468.7MAdded · 0.9% → 2.7%+2,871,298 shares
- Unitedhealth Group Inc~$445.4MAdded · 0.9% → 2.5%+900,425 shares
- Amazon~$355.8MAdded · 2.7% → 4.6%+1,972,702 shares
- Dollar Tree Inc~$342.4MNew · 0.0% → 1.3%+2,571,820 shares
- Workday~$322.4MAdded · 4.2% → 5.4%+1,181,863 shares
- Philip Morris Intl Inc~$310.9MAdded · 3.3% → 4.4%+3,392,949 shares
Largest sells
Since Q4 2023, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- United Parcel Service Inc~$1.29BSold out · 4.7% → 0.0%−8,199,127 shares
- Meta~$1.10BCut · 3.9% → 1.3%−2,259,650 shares
- Mckesson Corp~$881.8MCut · 3.8% → 1.2%−1,642,625 shares
- Progressive Corp~$585.4MCut · 3.4% → 2.3%−2,830,618 shares
- Deere & Co~$562.4MSold out · 2.1% → 0.0%−1,406,562 shares
- Alphabet~$460.1MSold out · 1.7% → 0.0%−3,293,461 shares
- General Electric Co~$413.3MCut · 2.4% → 1.8%−2,354,611 shares
- Rayzebio Inc~$413.0MSold out · 1.5% → 0.0%−6,642,700 shares
- Metlife Inc~$371.4MSold out · 1.4% → 0.0%−5,616,556 shares
- DoorDash~$345.0MSold out · 1.3% → 0.0%−3,489,066 shares
Holdings
As of Mar 31, 2024. Changes are in shares against Dec 31, 2023, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Visa Inc.COM CL A · shares +11% · price +7.2% | 6.6% | $1.77B | +$106.6M | ||||||||
| WorkdayCL A · shares +29% · price −1.2% | 5.4% | $1.44B | −$13.6M | ||||||||
| AmazonCOM · shares +40% · price +18.7% | 4.6% | $1.25B | +$140.2M | ||||||||
| Philip Morris Intl IncCOM · shares +35% · price −2.6% | 4.4% | $1.19B | −$23.7M | ||||||||
| Api Group CorpCOM STK · shares −16% · price +13.5% | 4.2% | $1.14B | +$135.4M | ||||||||
| Us Bancorp DelCOM NEW · shares +136% · price +3.3% | 3.8% | $1.01B | +$13.6M | ||||||||
| Las Vegas Sands CorpCOM · shares New | 3.3% | $874.9M | — | ||||||||
| Fortive CorpCOM · shares −9.8% · price +16.8% | 3.0% | $817.0M | +$117.7M | ||||||||
| Bridgebio Pharma IncCOM · shares 0% · price −23.4% | 2.9% | $776.7M | −$237.4M | ||||||||
| Roivant Sciences LtdSHS · shares 0% · price −6.1% | 2.7% | $731.1M | −$47.9M | ||||||||
| T-Mobile Us IncCOM · shares +190% · price +1.8% | 2.7% | $715.1M | +$4.4M | ||||||||
| AMDCOM · shares −17% · price +22.4% | 2.7% | $713.3M | +$130.7M | ||||||||
| Ameriprise Finl IncCOM · shares −15% · price +15.4% | 2.7% | $713.3M | +$95.3M | ||||||||
| Danaher CorporationCOM · shares −29% · price +7.9% | 2.6% | $708.7M | +$52.2M | ||||||||
| Unitedhealth Group IncCOM · shares +195% · price −6.0% | 2.5% | $673.4M | −$14.6M | ||||||||
| MicrosoftCOM · shares New | 2.5% | $671.8M | — | ||||||||
| AppleCOM · shares New | 2.5% | $663.8M | — | ||||||||
| Progressive CorpCOM · shares −48% · price +29.8% | 2.3% | $627.3M | +$144.2M | ||||||||
| Biomarin Pharmaceutical IncCOM · shares +31% · price −9.4% | 2.1% | $560.4M | −$44.4M | ||||||||
| General Electric CoCOM NEW · shares −46% · price +37.5% | 1.8% | $479.5M | +$130.9M | ||||||||
| Freeport-McMoRanCL B · shares −14% · price +10.5% | 1.7% | $447.5M | +$42.4M | ||||||||
| Cbre Group IncCL A · shares +20% · price +4.5% | 1.7% | $444.3M | +$15.8M | ||||||||
| MastercardCL A · shares −31% · price +12.9% | 1.4% | $382.5M | +$43.7M | ||||||||
| MetaCL A · shares −76% · price +37.2% | 1.3% | $355.4M | +$96.3M | ||||||||
| Royalty Pharma PlcSHS CLASS A · shares +14% · price +8.1% | 1.3% | $348.8M | +$23.0M | ||||||||
| Total · 83 positions | 100% | $26.86B | +$1.01B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q4 2023 to Q1 2024: 61 stocks held throughout, up $1.01B (+5.6%).
- Progressive Corp+$144.2M+30%
- Amazon+$140.2M+19%
- Api Group Corp+$135.4M+13%
- General Electric Co+$130.9M+38%
- AMD+$130.7M+22%
- Roivant Sciences Ltd−$47.9M−6%
- Adaptive Biotechnologies Cor−$50.7M−34%
- Hdfc Bank Ltd−$66.1M−17%
- Ginkgo Bioworks Holdings Inc−$75.8M−31%
- Bridgebio Pharma Inc−$237.4M−23%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 1 split read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $35.08B−2% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $35.75B−5% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $37.68B−2% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $38.50B+11% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $34.59B+10% | SEC ↗ |
| Q1 2025 | May 15, 2025 | $31.48B+2% | SEC ↗ |
| Q4 2024 | Feb 14, 2025 | $30.90B+13% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $27.44B+5% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $26.02B−3% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $26.86B−2% | SEC ↗ |
| Q4 2023 | Feb 14, 2024 | $27.30B+11% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 | $24.64B+1% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $24.43B+15% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $21.31B+7% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $19.98B−8% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $21.66B−1% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $21.86B−12% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $24.74B−29% | SEC ↗ |
| Q4 2021 | May 16, 2022 (amended) | $34.71B−5% | SEC ↗ |
| Q3 2021 | May 16, 2022 (amended) | $36.46B+11% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $32.98B−2% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $33.58B−8% | SEC ↗ |
| Q4 2020 | Feb 16, 2021 | $36.37B+31% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $27.68B+20% | SEC ↗ |
| Q2 2020 | Aug 7, 2020 | $23.14B+20% | SEC ↗ |
| Q1 2020 | May 13, 2020 | $19.21B−10% | SEC ↗ |
| Q4 2019 | Feb 13, 2020 | $21.35B+11% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $19.20B−14% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $22.29B+28% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $17.44B−1% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $17.57B−3% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $18.06B+3% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $17.47B+5% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $16.61B+2% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $16.26B+5% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $15.44B+4% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $14.85B−34% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $22.64B+3% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $22.01B−5% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $23.18B−2% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $23.54B+4% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $22.72B | SEC ↗ |